Description

Alerdez (dezloratadin) syrup 0.5 mg/ml. 50 ml. vial

Ingredients

Active ingredient: Dezloratadin
Other ingredients: Sucrose, citric acid, sodium benzoate, disodium edetate, propylene glycol, sorbitol, glycerol, purified water.

Dosage

Dosage: The recommended dose for adults and children over 12 years is 5 ml (2.5 mg) once daily. For children aged 6-12 years, the dose is 2.5 ml (1.25 mg) once daily.

Indications

Indications: Alerdez syrup is indicated for the relief of symptoms associated with allergic rhinitis and chronic idiopathic urticaria.

Contraindications

Contraindications: Alerdez syrup is contraindicated in patients with known hypersensitivity to dezloratadin or any of the ingredients in the formulation.

Directions

Directions: Shake well before use. Use the provided measuring device to ensure accurate dosage. Can be taken with or without food.

Scientific Evidence

Alerdez (dezloratadin) has been extensively studied for its efficacy in managing allergic conditions. Research published in the Journal of Allergy and Clinical Immunology has demonstrated the effectiveness of dezloratadin in relieving symptoms of allergic rhinitis with minimal sedative effects compared to other antihistamines.

Additional Information

It is important to note that Alerdez syrup may cause drowsiness in some individuals, so caution should be exercised when driving or operating machinery. Consult a healthcare professional before using this product if you are pregnant or breastfeeding.

Pharmacological Effects

Dezloratadin, the active ingredient in Alerdez syrup, is a non-sedating antihistamine that works by blocking the action of histamine in the body. Histamine is a substance that is released during an allergic reaction, causing symptoms such as itching, sneezing, and runny nose. By blocking histamine receptors, dezloratadin helps alleviate these symptoms without causing drowsiness.

Clinical Trials and Comparative Effectiveness

Clinical trials have shown that dezloratadin is effective in reducing symptoms of allergic rhinitis and chronic idiopathic urticaria. In comparative studies, dezloratadin has been found to have similar efficacy to other second-generation antihistamines but with a lower incidence of sedation, making it a preferred choice for many patients.

Overall, Alerdez (dezloratadin) syrup 0.5 mg/ml. 50 ml. vial is a well-tolerated and effective treatment option for allergic conditions, supported by scientific evidence and clinical trials.